P J Potter - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P J Potter

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

Journal of Clinical Pharmacology|May 2, 2003

Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injuryK C Hayes, M A Katz, J G Devane, et al.

Paraplegia|April 1, 1993

Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injuryK C Hayes, A R Blight, P J Potter, et al.

Journal of Neurotrauma|November 14, 1998

Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injuryP J Potter, K C Hayes, J L Segal, et al.

Journal of Clinical Pharmacology|April 13, 2000

Absorption characteristics of sustained-release 4-aminopyridine (fampridine SR) in patients with chronic spinal cord injuryJ L Segal, K C Hayes, S R Brunnemann, et al.

Spinal Cord|November 13, 2013

Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injuryD D Cardenas, J F Ditunno, V Graziani, et al.

Spinal Cord|July 25, 2007

Establishing evidence-based physical activity guidelines: methods for the Study of Health and Activity in People with Spinal Cord Injury (SHAPE SCI)K A Martin Ginis, A E Latimer, A C Buchholz, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

Journal of Clinical Pharmacology|May 2, 2003

Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injuryK C Hayes, M A Katz, J G Devane, et al.

Paraplegia|April 1, 1993

Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injuryK C Hayes, A R Blight, P J Potter, et al.

Journal of Neurotrauma|November 14, 1998

Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injuryP J Potter, K C Hayes, J L Segal, et al.

Journal of Clinical Pharmacology|April 13, 2000

Absorption characteristics of sustained-release 4-aminopyridine (fampridine SR) in patients with chronic spinal cord injuryJ L Segal, K C Hayes, S R Brunnemann, et al.

Spinal Cord|November 13, 2013

Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injuryD D Cardenas, J F Ditunno, V Graziani, et al.

Spinal Cord|July 25, 2007

Establishing evidence-based physical activity guidelines: methods for the Study of Health and Activity in People with Spinal Cord Injury (SHAPE SCI)K A Martin Ginis, A E Latimer, A C Buchholz, et al.

Pageof 4